Cryptosporidiosis: From Prevention to Treatment, a Narrative Review

Yosra A Helmy1, Hafez M Hafez2

  • 1Department of Veterinary Science, College of Agriculture, Food, and Environment, University of Kentucky, Lexington, KY 40546, USA.

Microorganisms
|December 23, 2022
PubMed

Insights

Cryptosporidiosis is a zoonotic disease caused by Cryptosporidium parasites, affecting both humans and animals. Understanding its transmission and implementing a One Health approach are crucial for control, as effective treatments and vaccines are lacking.

Area of Science:

  • Veterinary Medicine
  • Infectious Diseases
  • Parasitology

Background:

  • Cryptosporidiosis is a significant water- and food-borne zoonotic disease caused by *Cryptosporidium* parasites.
  • Key species, *C. hominis* and *C. parvum*, infect humans and animals, with transmission via fecal-oral and respiratory routes.
  • The parasite's oocysts are resistant to common disinfectants, and effective treatments or vaccines are currently unavailable.

Purpose of the Study:

  • To provide a comprehensive review of cryptosporidiosis, covering its biology, transmission, and epidemiology.
  • To explore current challenges in diagnosis, treatment, and control of *Cryptosporidium* infections.
  • To highlight the importance of the One Health approach in managing this zoonotic disease.

Main Methods:

  • Literature review synthesizing data on *Cryptosporidium* biology, pathogenesis, and transmission dynamics.
  • Analysis of epidemiological data, including outbreaks, host spectrum, and risk factors.
  • Examination of current diagnostic and therapeutic strategies and vaccine development prospects.

Main Results:

  • *Cryptosporidium* exhibits complex transmission cycles across animal and human populations.
  • Genomics, epidemiology, and outbreak data reveal critical insights into disease spread.
  • The One Health framework is essential for integrated management at the animal-human-environmental interface.

Conclusions:

  • A thorough understanding of cryptosporidiosis is vital for developing effective control strategies.
  • Integrated approaches, including the One Health strategy, are necessary to mitigate future *Cryptosporidium* infections.
  • Further research into vaccines and novel therapeutics is needed to combat this persistent zoonotic disease.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
75
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
8.5K
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
23
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
260
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.7K